AU2002356425A1 - A process for manufacture of a sustained release composition containing microbe - Google Patents
A process for manufacture of a sustained release composition containing microbeInfo
- Publication number
- AU2002356425A1 AU2002356425A1 AU2002356425A AU2002356425A AU2002356425A1 AU 2002356425 A1 AU2002356425 A1 AU 2002356425A1 AU 2002356425 A AU2002356425 A AU 2002356425A AU 2002356425 A AU2002356425 A AU 2002356425A AU 2002356425 A1 AU2002356425 A1 AU 2002356425A1
- Authority
- AU
- Australia
- Prior art keywords
- manufacture
- composition containing
- sustained release
- release composition
- containing microbe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000013268 sustained release Methods 0.000 title 1
- 239000012730 sustained-release form Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1106MU2001 | 2001-11-21 | ||
| IN1106/MUM/2001 | 2001-11-21 | ||
| PCT/IN2002/000223 WO2003043610A2 (en) | 2001-11-21 | 2002-11-20 | A process for manufacture of a sustained release composition containing microbe |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002356425A1 true AU2002356425A1 (en) | 2003-06-10 |
| AU2002356425A8 AU2002356425A8 (en) | 2003-06-10 |
Family
ID=11097321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002356425A Abandoned AU2002356425A1 (en) | 2001-11-21 | 2002-11-20 | A process for manufacture of a sustained release composition containing microbe |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1448173A2 (en) |
| AU (1) | AU2002356425A1 (en) |
| HU (1) | HUP0500382A3 (en) |
| WO (1) | WO2003043610A2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2885807B1 (en) * | 2005-05-18 | 2008-05-16 | Mg Pharma | SOLID PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF 1- (2,3,4-TRIMETHOXYBENZYL) PIPERAZINE, AND PREPARATION METHOD |
| WO2009034541A2 (en) | 2007-09-11 | 2009-03-19 | Ranbaxy Laboratories Limited | Controlled release pharmaceutical dosage forms of trimetazidine |
| TR201001902A2 (en) | 2010-03-12 | 2011-04-21 | Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. | Trimetazidine tablets with extended release |
| ES2508490T3 (en) | 2010-05-04 | 2014-10-16 | Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi | Formulation of trimetazidine with different release profiles |
| CN102133195A (en) * | 2011-03-17 | 2011-07-27 | 王国栋 | Trimetazidine dihydrochloride sustained control release pellet and preparation method thereof |
| FR2986431B1 (en) * | 2012-02-03 | 2017-03-17 | Servier Lab | PROLONGED RELEASE OF TRIMETAZIDINE PHARMACEUTICAL COMPOSITION, PROCESS FOR THE PRODUCTION THEREOF AND USE IN THERAPEUTIC TREATMENTS |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2717687B1 (en) * | 1994-03-24 | 1996-06-14 | Adir | Pharmaceutical compositions for the sustained release of trimetazidine after oral administration. |
-
2002
- 2002-11-20 AU AU2002356425A patent/AU2002356425A1/en not_active Abandoned
- 2002-11-20 EP EP02803493A patent/EP1448173A2/en not_active Ceased
- 2002-11-20 HU HU0500382A patent/HUP0500382A3/en unknown
- 2002-11-20 WO PCT/IN2002/000223 patent/WO2003043610A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0500382A3 (en) | 2008-03-28 |
| HUP0500382A2 (en) | 2005-07-28 |
| WO2003043610A2 (en) | 2003-05-30 |
| AU2002356425A8 (en) | 2003-06-10 |
| EP1448173A2 (en) | 2004-08-25 |
| WO2003043610A3 (en) | 2003-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002248377A1 (en) | A controlled release pharmaceutical composition | |
| EP1385486A4 (en) | A novel coating for a sustained release pharmaceutical composition | |
| AU2002259025A1 (en) | Reforming process for manufacture of para-xylene | |
| AU2003287639A1 (en) | Methods of forming a supported activated catalyst composition | |
| AU2002352353A1 (en) | Process for production of styrene | |
| AU2002337967A1 (en) | Extended release composition containing tramadol | |
| AU2003244157A1 (en) | Process for producing sustained-release composition | |
| AU2003283870A1 (en) | Process for preparing a composition | |
| AU2003208595A1 (en) | Process for the preparation of pure silica | |
| AU2002353366A1 (en) | The process of manufacturing a pharmaceutical composition useful for management of cancer | |
| AU2002356425A1 (en) | A process for manufacture of a sustained release composition containing microbe | |
| AU2002366017A1 (en) | Process for producing (meth)acrylic acid compounds | |
| AU2003209533A1 (en) | Process of manufacturing pharmaceutical composition useful for management of tuberculosis | |
| AU2002310898A1 (en) | Process for the preparation of a polymer-amine | |
| EP1215193A3 (en) | Production of 2-hydrocarbyl-2-adamantyl acrylate compounds | |
| AU2002308986A1 (en) | Process for preparation of a quinolinecarbaldehyde | |
| EP1243564A3 (en) | Process for preventing formation of scale | |
| AU2003243432A1 (en) | Process of making phosphordiamidite compounds | |
| AU2001233180A1 (en) | Method of preparing a sustained release composition | |
| AU2002250829A1 (en) | Process for the preparation of a polymerisable dental composition | |
| AUPR144100A0 (en) | Process for can manufacture | |
| AU2003235129A1 (en) | Process for preparation of 2-aminoketones | |
| AU2002344645A1 (en) | Process for producing bisbenzil compounds | |
| HK1067864A (en) | Compounds for a controlled release of active molecules | |
| AU2001279511A1 (en) | Process for obtaining a pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |